392-17-6 Usage
Description
(2,6-dichloro-4-fluorophenoxy)acetic acid, also known as 2,6-Dichloro-4-fluorophenoxyacetic acid or 2,6-DFPA, is a synthetic organic compound that functions as a herbicide and plant growth regulator. It is designed to control broadleaf weeds in various crops, including wheat, barley, rice, and sugarcane. This chemical operates by disrupting the growth hormones in the target plants, causing them to grow uncontrollably and ultimately leading to their death. When used according to the recommended guidelines, 2,6-Dichloro-4-fluorophenoxyacetic acid is considered to be relatively safe for humans and the environment. However, it is crucial to handle and apply this chemical with caution and to follow proper safety measures to minimize any potential risks.
Uses
Used in Agricultural Industry:
(2,6-dichloro-4-fluorophenoxy)acetic acid is used as a herbicide for controlling broadleaf weeds in various crops such as wheat, barley, rice, and sugarcane. It is effective in managing unwanted plant growth that can compete with the desired crops for resources, thereby improving crop yield and quality.
Used in Plant Growth Regulation:
(2,6-dichloro-4-fluorophenoxy)acetic acid also serves as a plant growth regulator, which can be utilized to manipulate the growth patterns of certain plants. This application can be beneficial in various agricultural practices where controlling plant growth is necessary for optimal crop management and production.
Check Digit Verification of cas no
The CAS Registry Mumber 392-17-6 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 3,9 and 2 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 392-17:
(5*3)+(4*9)+(3*2)+(2*1)+(1*7)=66
66 % 10 = 6
So 392-17-6 is a valid CAS Registry Number.
392-17-6Relevant articles and documents
Design and synthesis of Rho kinase inhibitors (I)
Takami, Atsuya,Iwakubo, Masayuki,Okada, Yuji,Kawata, Takehisa,Odai, Hideharu,Takahashi, Nobuaki,Shindo, Kazutoshi,Kimura, Kaname,Tagami, Yoshimichi,Miyake, Mika,Fukushima, Kayoko,Inagaki, Masaki,Amano, Mutsuki,Kaibuchi, Kozo,Iijima, Hiroshi
, p. 2115 - 2137 (2007/10/03)
Several structurally unrelated scaffolds of the Rho kinase inhibitor were designed using pharmacophore information obtained from the results of a high-throughput screening and structural information from a homology model of Rho kinase. A docking simulation using the ligand-binding pocket of the Rho kinase model helped to comprehensively understand and to predict the structure-activity relationship of the inhibitors. This understanding was useful for developing new Rho kinase inhibitors of higher potency and selectivity. We identified several potent platforms for developing the Rho kinase inhibitors, namely, pyridine, 1H-indazole, isoquinoline, and phthalimide.
